BR9610876A - Inibidores de protease de guanidino - Google Patents
Inibidores de protease de guanidinoInfo
- Publication number
- BR9610876A BR9610876A BR9610876A BR9610876A BR9610876A BR 9610876 A BR9610876 A BR 9610876A BR 9610876 A BR9610876 A BR 9610876A BR 9610876 A BR9610876 A BR 9610876A BR 9610876 A BR9610876 A BR 9610876A
- Authority
- BR
- Brazil
- Prior art keywords
- guanidine
- protease inhibitors
- compounds
- formula
- solvates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53693995A | 1995-09-29 | 1995-09-29 | |
US08/698,401 US5792769A (en) | 1995-09-29 | 1996-08-15 | Guanidino protease inhibitors |
PCT/US1996/015609 WO1997011693A1 (en) | 1995-09-29 | 1996-09-27 | Guanidino protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9610876A true BR9610876A (pt) | 1999-07-13 |
Family
ID=27065321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9610876A BR9610876A (pt) | 1995-09-29 | 1996-09-27 | Inibidores de protease de guanidino |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0859607B1 (pt) |
JP (1) | JPH11512722A (pt) |
AT (1) | ATE229800T1 (pt) |
AU (1) | AU714292C (pt) |
BR (1) | BR9610876A (pt) |
CA (1) | CA2233344A1 (pt) |
CZ (1) | CZ92298A3 (pt) |
DE (1) | DE69625505T2 (pt) |
ES (1) | ES2191109T3 (pt) |
HU (1) | HUP9802764A3 (pt) |
IL (1) | IL123802A0 (pt) |
NO (1) | NO981393L (pt) |
NZ (1) | NZ319474A (pt) |
PL (1) | PL325954A1 (pt) |
WO (1) | WO1997011693A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2256309C (en) | 1995-12-29 | 2006-08-15 | 3-Dimensional Pharmaceuticals, Inc. | Amidino protease inhibitors |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
JP2002510313A (ja) | 1997-06-26 | 2002-04-02 | イーライ・リリー・アンド・カンパニー | 抗血栓物質 |
JP4495339B2 (ja) * | 1998-03-23 | 2010-07-07 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | ピペリジニルおよびn−アミジノピペリジニル誘導体 |
US6344486B1 (en) | 1998-04-03 | 2002-02-05 | 3-Dimensional Pharmaceuticals, Inc. | Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
SI1086122T1 (sl) | 1998-06-11 | 2006-02-28 | Pment L L C Johnson & Johnson | Inhibitorji pirazinon-proteaze |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
WO2002006248A2 (en) | 2000-07-17 | 2002-01-24 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine pyrazinones as protease inhibitors |
AU2001277242A1 (en) | 2000-08-04 | 2002-02-18 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
US6486174B2 (en) | 2000-08-07 | 2002-11-26 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
UA75093C2 (en) | 2000-10-06 | 2006-03-15 | Dimensional Pharm Inc | Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors |
US7479502B2 (en) | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3577432A (en) * | 1968-12-23 | 1971-05-04 | Robins Co Inc A H | 1-substituted-3-phenoxypyrrolidines |
JPS537436B2 (pt) * | 1974-04-16 | 1978-03-17 | ||
US4433152A (en) * | 1981-05-25 | 1984-02-21 | Nippon Chemiphar Co., Ltd. | Amidinopiperidine derivatives |
TW201303B (pt) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche |
-
1996
- 1996-09-27 EP EP96933186A patent/EP0859607B1/en not_active Expired - Lifetime
- 1996-09-27 JP JP9513732A patent/JPH11512722A/ja active Pending
- 1996-09-27 AT AT96933186T patent/ATE229800T1/de not_active IP Right Cessation
- 1996-09-27 CA CA002233344A patent/CA2233344A1/en not_active Abandoned
- 1996-09-27 BR BR9610876A patent/BR9610876A/pt unknown
- 1996-09-27 IL IL12380296A patent/IL123802A0/xx unknown
- 1996-09-27 AU AU72012/96A patent/AU714292C/en not_active Ceased
- 1996-09-27 CZ CZ98922A patent/CZ92298A3/cs unknown
- 1996-09-27 PL PL96325954A patent/PL325954A1/xx unknown
- 1996-09-27 DE DE69625505T patent/DE69625505T2/de not_active Expired - Fee Related
- 1996-09-27 ES ES96933186T patent/ES2191109T3/es not_active Expired - Lifetime
- 1996-09-27 WO PCT/US1996/015609 patent/WO1997011693A1/en active IP Right Grant
- 1996-09-27 HU HU9802764A patent/HUP9802764A3/hu unknown
- 1996-09-27 NZ NZ319474A patent/NZ319474A/xx unknown
-
1998
- 1998-03-27 NO NO981393A patent/NO981393L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE229800T1 (de) | 2003-01-15 |
ES2191109T3 (es) | 2003-09-01 |
AU714292B2 (en) | 1999-12-23 |
EP0859607B1 (en) | 2002-12-18 |
AU714292C (en) | 2001-11-01 |
NZ319474A (en) | 2000-01-28 |
DE69625505T2 (de) | 2003-11-13 |
CZ92298A3 (cs) | 1998-07-15 |
HUP9802764A3 (en) | 2000-03-28 |
NO981393D0 (no) | 1998-03-27 |
NO981393L (no) | 1998-05-25 |
EP0859607A4 (en) | 1999-05-06 |
WO1997011693A1 (en) | 1997-04-03 |
CA2233344A1 (en) | 1997-04-03 |
PL325954A1 (en) | 1998-08-17 |
DE69625505D1 (de) | 2003-01-30 |
EP0859607A1 (en) | 1998-08-26 |
IL123802A0 (en) | 1998-10-30 |
AU7201296A (en) | 1997-04-17 |
JPH11512722A (ja) | 1999-11-02 |
HUP9802764A2 (hu) | 1999-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9612360A (pt) | Inibidores de amidino protease | |
IL126610A0 (en) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors | |
DE69736777D1 (de) | Amidinohydrazone als protease-inhibitoren | |
SE9504661D0 (sv) | New compounds | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
DK0892780T3 (da) | m-Amidinophenylanaloger som faktor Xa-inhibitorer | |
MY116539A (en) | New amino acid derivatives | |
BR9610876A (pt) | Inibidores de protease de guanidino | |
MX9703564A (es) | Inhibidores de proteasa multicatalitica. | |
DE59702414D1 (de) | Dipeptidische benzamidine als kininogenasen-inhibitoren | |
MXPA98002443A (es) | Inhibidores de guanidino proteasas. | |
NO934628L (no) | Retrovirus-protease-inhibitorer | |
YU21100A (sh) | Izohinolini kao urokinazni inhibitori | |
CA2317604A1 (en) | Matrix metalloprotease inhibitors | |
CA2024162A1 (en) | Benzazabicyclo carbamates as novel cholinesterase inhibitors | |
SE9504662D0 (sv) | New compounds | |
TR200100133T2 (tr) | FKBP İnhibitörleri | |
UA26459C2 (uk) | Іhгібітор впливу амілоїдhих білків | |
HUP9902633A3 (en) | Phenylethanolaminotetralincarboxamide derivatives and pharmaceutical compositions containing them | |
TH8579EX (th) | อนุพันธ์ของไกลซีน | |
TH8579A (th) | อนุพันธ์ของไกลซีน | |
AP2001002047A0 (en) | Isoquinoliness as urokinase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |